WIBR3_SNCA_A30P_E1-3
WIBRe001-A-76
General
Cell Line |
|
| hPSCreg name | WIBRe001-A-76 |
| Cite as: | WIBRe001-A-76 |
| Alternative name(s) |
WIBR3_SNCA_A30P_E1-3
|
| Cell line type | Human embryonic stem cell (hESC) |
| Similar lines |
WIBRe001-A-75 (WIBR3_SNCA_A30P_A2-3) EDi001-A-2 (AST23-1KO-3, AST22-1KO-3, AST-23_SCAKO Clone 3, AST-22_SNCAKO Clone 3) Donor's gene variants: SNCA, SNCA, SNCA, SNCA Donor diseases: Parkinson disease EDi001-A-3 (AST23_SNCAKO Clone 1, AST22-1KO-1, AST23-1KO-1, AST22_SNCAKO Clone 1) Donor's gene variants: SNCA, SNCA, SNCA, SNCA Donor diseases: Parkinson disease EDi001-A-4 (AST22-2KO-6, AST23_SNCAKO Clone 6, AST22_SNCAKO Clone 6, AST23-2KO-6) Donor's gene variants: SNCA, SNCA, SNCA, SNCA Donor diseases: Parkinson disease WIBRe001-A (WIBR38, WIBR3) CBIGi001-A-18 (IPSC0083, SNCA-KO/AIW002-02) CBIGi001-A-15 (SNCA A30P/AIW002-02, IPSC0080) CBIGi001-A-16 (IPSC0081, SNCA A53T/AIW002-02) CBIGi001-A-17 (IPSC0082, SNCA E46K/AIW002-02) WIBRe001-A-58 (WIBR3_VPS13C_FS_Homo_H3-1) WIBRe001-A-59 (WIBR3_VPS13C_A444P_Het_E12-1) WIBRe001-A-60 (WIBR3_VPS13C_A444P_Homo_C8-2) WIBRe001-A-5 (WIBR3_PRKN_X3DEL_F2-5) WIBRe001-A-6 (WIBR3_PRKN_X3DEL_H2-2) WIBRe001-A-7 (WIBR3_SNCA_A30P_A2-3) WIBRe001-A-8 (WIBR3_SNCA_A30P_E1-3) WIBRe001-A-9 (WIBR3_FBXO7_R498X_A7-1) WIBRe001-A-10 (WIBR3_FBXO7_FS_A3-1) WIBRe001-A-11 (WIBR3_PINK1_Q129X_C4-1) WIBRe001-A-12 (WIBR3_PINK1_Q129X_E2-2) WIBRe001-A-13 (WIBR3_PINK1_Q129X_E7-1) WIBRe001-A-15 (WIBR3_DNAJC6_c.801-2 A>G+FS/c.801-2 A>G_G12-2) WIBRe001-A-16 (WIBR3_DNAJC6_FS/FS_H10-1) WIBRe001-A-17 (WIBR3_GBA1_IVS2_G2E) WIBRe001-A-18 (WIBR3_GBA1_IVS2_E10B) WIBRe001-A-19 (WIBR3_SNCA_A53T_1) WIBRe001-A-20 (WIBR3_SNCA_A53T_2) WIBRe001-A-21 (WIBR3_SNCA_A53T_4) WIBRe001-A-22 (WIBR3_LRRK2_G2019S_5_Het) WIBRe001-A-23 (WIBR3_LRRK2_G2019S_6_Het) WIBRe001-A-24 (WIBR3_LRRK2_G2019S_216_Het) WIBRe001-A-25 (WIBR3_LRRK2_G2019S_65_Homo) WIBRe001-A-26 (WIBR3_DJ1_X1-5DEL_2860) WIBRe001-A-27 (WIBR3_DJ1_X1-5DEL_2872) WIBRe001-A-28 (WIBR3_DJ1_X1-5DEL_2876) WIBRe001-A-74 (WIBR3_FBXO7_R498X_A7-1) WIBRe001-A-61 (WIBR3_DJ1_X1-5DEL_Het_2036) WIBRe001-A-62 (WIBR3_DJ1_X1-5DEL_Het_2038) WIBRe001-A-32 (WIBR3_EWT_S1) |
| Last update | 4th December 2025 |
| User feedback | |
Provider |
|
| Generator | Albert Einstein College of Medicine (AECM) |
| Distributors | |
External Databases |
|
| BioSamples | SAMEA118448013 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | female |
| Ethnicity | unknown |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
| Family history | no |
| Is the medical history available upon request? | no |
| Is clinical information available? | no |
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
| BioSamples | SAMEA104129930 |
Ethics
Also have a look at the ethics information for the parental line
WIBRe001-A
.
hESC Derivation
|
The source cell information can be found in the parental cell line
WIBRe001-A.
|
Culture Conditions
| Medium |
Other medium:
Base medium: DMEM/F12
Main protein source: Fetal bovine serum Serum concentration: 15 % |
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| Alkaline Phosphatase |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|
||||
| SSEA-4 |
Yes |
|
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
|
Other Genotyping (Cell Line) |
|
Genetic Modification
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.